Johnson & Johnson Stock Has 33% Upside, According to 1 Wall Street Analyst

As financial analysts know, no rule says large and long-lived companies need to be slowly growing investments. In that vein, Cantor Fitzgerald analyst Louise Chen on Feb. 20 reaffirmed her price target of $215 for Johnson & Johnson (JNJ 0.12%), suggesting that the stock could climb by as much as 33% from its current price near $161. Chen's estimate is an outlier, as the average price target of the financial analysts covering the stock is $175.But, in the context of the company being one of the world's bigge ...